LTIMindtree gets 7-yr contract worth $100 mln from European medical tech firm
This story was originally published at 14:49 IST on 23 February 2026
Register to read our real-time news.Informist, Monday, Feb. 23, 2026
--LTIMindtree signs $100-mln multi-year agreement with MedTech co in Europe
--LTIMindtree: Agreement with Europe co is for over 7 years
NEW DELHI – LTIMindtree Ltd. got a multi-year contract valued at $100 million from a Europe-based medical technology company that provides hearing solutions. The contract spans seven years for product development and support across the client's flagship offerings.
Under the deal, LTIMindtree will develop and support the medical technology company's primary hearing instrument brands and private labels using the iNXT platform. The work includes developing wearable hearing devices, a fitting application used by hearing care professionals to configure hearing aids, and a mobile application for controlling devices. In addition to technology development, LTIMindtree will manage compliance and regulatory requirements specific to the medical technology sector for the client.
For the December quarter, LTIMindtree reported a net profit of INR 9.71 billion on a revenue of INR 107.81 billion. At 1332 IST, shares of the company were down over 1% at INR 4,816 on the National Stock Exchange. End
US$1 = INR 90.85
IST, or Indian Standard Time, is five-and-a-half hours ahead of GMT
Reported by Gunjan Rajput
Edited by Rajeev Pai
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2026. All rights reserved.
To read more please subscribe
Share this Story:
